To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SLC25A36TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
556 supporting clones for gene SLC25A36 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BE612465 adenocarcinoma, ovary .a 1 to 117 1 to 117   tiling clone, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 117/117
(100 %)
0 diff
(100 %id)
AK296785 tongue, tumor tissue .a 38 to 1077 1 to 1040   tiling clone,   1040/1040
(100 %)
2 diff
(99.9 %id)
DC346198 tongue, tumor tissue .a 38 to 605 1 to 570       570/570
(100 %)
3 diff
(99.5 %id)
BE962532 adenocarcinoma, ovary .a 442 to 1072 660 to 16   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 645/645
(100 %)
32 diff
(95.1 %id)
NM_001104647.1   .b -10 to 4650 1 to 4661 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 4661/4661
(100 %)
2 diff
(100.0 %id)
DA593079 lung .b -9 to 468 2 to 479   tiling clone, capped   478/478
(100 %)
0 diff
(100 %id)
BE383668 melanotic melanoma, skin .b 6 to 800 1 to 793       793/794
(99 %)
32 diff
(96.0 %id)
DA510050 brain .b 7 to 542 2 to 537   capped   536/554
(96 %)
1 diff
(99.9 %id)
BI668712 brain, hypothalamus .b 7 to 592 1 to 591       591/591
(100 %)
24 diff
(96.0 %id)
BG536670 lung .b 12 to 673 1 to 666       664/791
(83 %)
19 diff
(97.6 %id)
DB478227 hippocampus .b 13 to 492 1 to 480       480/480
(100 %)
0 diff
(100 %id)
DB496597 hypothalamus .b 13 to 514 1 to 501       501/501
(100 %)
1 diff
(99.9 %id)
DB498882 hypothalamus .b 13 to 517 1 to 505       505/505
(100 %)
1 diff
(99.9 %id)
TI_44344148   .b 13 to 592 87 to 671       585/671
(87 %)
12 diff
(98.3 %id)
DA144147 amygdala .b 14 to 311 2 to 299   capped   298/298
(100 %)
1 diff
(99.7 %id)
DB466391 hippocampus .b 16 to 441 1 to 426       426/426
(100 %)
4 diff
(99.1 %id)
DB503109 hypothalamus .b 16 to 491 1 to 476       476/476
(100 %)
0 diff
(100 %id)
AU129403   .b 16 to 496 2 to 482   capped   481/481
(100 %)
0 diff
(100 %id)
DB476192 hippocampus .b 17 to 499 1 to 483       483/483
(100 %)
0 diff
(100 %id)
DB476425 hippocampus .b 17 to 507 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BG704985 brain, hippocampus .b 18 to 819 1 to 801       801/802
(99 %)
10 diff
(98.8 %id)
BI561319 testis .b 18 to 730 1 to 713       713/713
(100 %)
2 diff
(99.8 %id)
TI_44350963   .b 18 to 730 123 to 835       713/835
(85 %)
0 diff
(100 %id)
BM014079 breast, mammary adenocarcinoma, cell line .b 20 to 170 1 to 151       151/151
(100 %)
0 diff
(100 %id)
CN256027 embryonic stem cells, DMSO-treated H9 cellline .b 23 to 567 9 to 553       545/553
(98 %)
0 diff
(100 %id)
AA148764   .b 24 to 403 1 to 379       379/379
(100 %)
9 diff
(97.7 %id)
AV702549 adrenal gland .b 28 to 543 1 to 516       516/700
(73 %)
4 diff
(99.5 %id)
DB468133 hippocampus .b 32 to 461 1 to 430       430/430
(100 %)
7 diff
(98.4 %id)
DA755920   .b 33 to 315 2 to 285   capped   284/284
(100 %)
1 diff
(99.7 %id)
DA964708 stomach .b 33 to 581 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DB483198 hippocampus .b 36 to 527 1 to 492       492/492
(100 %)
0 diff
(100 %id)
BQ581790 insulinoma, Pancreas .b 43 to 575 1 to 533     Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 533/533
(100 %)
7 diff
(98.7 %id)
DB450388 testis .b 46 to 504 1 to 458       458/459
(99 %)
3 diff
(99.4 %id)
BP347111 brain .b 46 to 626 1 to 581       583/581
(100 %)
23 diff
(96.1 %id)
BC014064 Placenta, choriocarcinoma .b 57 to 1343 1 to 1287 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 1287/1287
(100 %)
0 diff
(100 %id)
BM311247 Pancreas, Purified pancreatic islet .b 57 to 609 18 to 570       553/570
(97 %)
0 diff
(100 %id)
BE735315 choriocarcinoma, placenta .b 62 to 914 30 to 867       838/1018
(82 %)
30 diff
(97.1 %id)
BG167319 hypernephroma, cell line, Kidney .b 65 to 170 1 to 105   available from MGC,   105/105
(100 %)
1 diff
(99.1 %id)
DA771541 brain .b 82 to 657 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BU600930 mixed (pool of 40 RNAs) .b 83 to 833 1 to 755       755/824
(91 %)
13 diff
(98.5 %id)
CK821679 Pancreas, Purified pancreatic islet .b 92 to 674 1 to 583     Submitted on the opposite strand 583/583
(100 %)
0 diff
(100 %id)
BF850159 lung_normal .b 127 to 412 1 to 286       286/296
(96 %)
2 diff
(99.4 %id)
CV028537 mixed .b 225 to 761 1 to 537       537/537
(100 %)
0 diff
(100 %id)
TI_1948091407   .b 225 to 831 126 to 733       608/1382
(43 %)
26 diff
(98.2 %id)
AA160974   .b 256 to 790 1 to 534       534/535
(99 %)
13 diff
(97.6 %id)
AA101937 colon, tumor .b 268 to 689 14 to 435       422/435
(97 %)
1 diff
(99.8 %id)
AI768269 pooled .b 270 to 333 64 to 1       64/64
(100 %)
1 diff
(98.5 %id)
AW672908 cervix .b 482 to 860 1 to 380       380/383
(99 %)
2 diff
(99.5 %id)
FE192850   .b 528 to 782 1 to 255       255/255
(100 %)
9 diff
(96.5 %id)
TI_151775766   .b 560 to 1199 87 to 731       645/883
(73 %)
9 diff
(99.0 %id)
BE502676 pooled germ cell tumors .b 606 to 1183 578 to 1       578/587
(98 %)
14 diff
(97.7 %id)
DA417556 thalamus .b 609 to 1146 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
CN410534 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 610 to 1343 1 to 734   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 734/734
(100 %)
2 diff
(99.8 %id)
H97124 melanocyte .b 610 to 671 1 to 61       61/61
(100 %)
1 diff
(98.4 %id)
BF059435 pooled germ cell tumors .b 610 to 1183 576 to 1       576/576
(100 %)
1 diff
(99.9 %id)
BE814424 breast_normal .b 615 to 966 416 to 65       352/416
(84 %)
0 diff
(100 %id)
BE466032 pooled germ cell tumors .b 628 to 1065 438 to 1       438/439
(99 %)
16 diff
(96.4 %id)
AI694452 carcinoid, lung .b 630 to 1349 720 to 1       722/723
(99 %)
7 diff
(99.1 %id)
AI634396 pooled germ cell tumors .b 633 to 1183 550 to 1       550/550
(100 %)
3 diff
(99.5 %id)
BF058217 fibrotheoma, ovary .b 643 to 1343 703 to 1       703/705
(99 %)
11 diff
(98.5 %id)
AA127707 uterus .b 652 to 997 1 to 346   fully sequenced,   346/346
(100 %)
1 diff
(99.8 %id)
BM673781 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 660 to 1343 702 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 684/684
(100 %)
0 diff
(100 %id)
DA247536 brain .b 667 to 1265 2 to 600   capped   599/600
(99 %)
1 diff
(99.9 %id)
DB217814 trachea .b 676 to 1236 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
CA772340 Pancreas, Purified pancreatic islet .b 677 to 997 58 to 379   fully sequenced,   322/379
(84 %)
4 diff
(99.0 %id)
AA317157 lung .b 683 to 902 1 to 220       220/220
(100 %)
0 diff
(100 %id)
AI431745 Kidney .b 685 to 1346 662 to 1       662/663
(99 %)
4 diff
(99.4 %id)
BE670569 carcinoid, lung .b 687 to 1346 660 to 1       660/663
(99 %)
2 diff
(99.7 %id)
BM994189 lung, Metastatic Chondrosarcoma .b 688 to 1343 674 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 656/656
(100 %)
0 diff
(100 %id)
AI479348 pooled .b 693 to 1343 651 to 1       651/651
(100 %)
0 diff
(100 %id)
AW298074   .b 695 to 1200 506 to 1       506/506
(100 %)
0 diff
(100 %id)
BQ581474 insulinoma, Pancreas .b 696 to 1343 663 to 16   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 648/648
(100 %)
0 diff
(100 %id)
DA800105 brain .b 709 to 1251 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
AI819738 2 pooled tumors (clear cell type), Kidney .b 714 to 1348 635 to 1       635/635
(100 %)
3 diff
(99.6 %id)
AW779732 Kidney .b 717 to 1343 627 to 1       627/627
(100 %)
3 diff
(99.6 %id)
DA235399 brain .b 718 to 1302 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
BP380210 uterus .b 722 to 1279 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
AI636201 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 723 to 1343 619 to 1       619/619
(100 %)
7 diff
(98.9 %id)
BF938966 carcinoid, lung .b 726 to 1346 621 to 1       621/621
(100 %)
2 diff
(99.7 %id)
AU117733 whole embryo, mainly head .b 737 to 1519 2 to 787   capped   786/788
(99 %)
9 diff
(98.9 %id)
AW967042   .b 749 to 1294 1 to 548       548/548
(100 %)
20 diff
(96.4 %id)
AI979011 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 750 to 1345 591 to 1       591/596
(99 %)
6 diff
(99.0 %id)
DB136920 thymus .b 782 to 1331 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
AW999434 breast_normal .b 788 to 966 214 to 36     Submitted on the opposite strand 179/214
(83 %)
0 diff
(100 %id)
CR602139 B cells (Ramos cell line) Cot 25-normalized .b 815 to 1343 1 to 529   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 529/529
(100 %)
0 diff
(100 %id)
BX331108   .b 815 to 1340 525 to 1       525/525
(100 %)
4 diff
(99.3 %id)
BX363508   .b 815 to 1343 1 to 529   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 529/529
(100 %)
1 diff
(99.9 %id)
BX386746   .b 815 to 1343 1 to 529   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 529/529
(100 %)
2 diff
(99.7 %id)
AA160975   .b 820 to 1343 522 to 1       522/523
(99 %)
6 diff
(98.9 %id)
AU127527   .b 823 to 1608 2 to 793   capped   792/795
(99 %)
10 diff
(98.8 %id)
DA093383 cerebellum .b 836 to 1410 2 to 579   capped   578/579
(99 %)
5 diff
(99.2 %id)
AI193979 lung .b 855 to 1343 491 to 1       491/491
(100 %)
2 diff
(99.6 %id)
AI611182 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 861 to 1157 297 to 1       297/297
(100 %)
0 diff
(100 %id)
AI808476 pooled .b 861 to 1309 489 to 41       449/489
(91 %)
0 diff
(100 %id)
BE041823 pooled .b 861 to 1343 499 to 17   AAA Submitted on the opposite strand 483/483
(100 %)
6 diff
(98.8 %id)
AI261728 Kidney .b 862 to 1044 183 to 1       183/184
(99 %)
18 diff
(90.3 %id)
AI220151 pooled .b 865 to 1342 478 to 1       478/482
(99 %)
0 diff
(100 %id)
AA829482 germinal center B cell .b 867 to 1352 486 to 1       486/486
(100 %)
1 diff
(99.8 %id)
AA923724 pooled .b 867 to 1343 477 to 1       477/477
(100 %)
0 diff
(100 %id)
DB567621 hypothalamus .b 876 to 1343 1 to 468     Submitted on the opposite strand 468/468
(100 %)
0 diff
(100 %id)
AA101938 colon, tumor .b 888 to 1343 458 to 1       458/467
(98 %)
2 diff
(99.6 %id)
AI038574   .b 890 to 1345 455 to 1       455/455
(100 %)
1 diff
(99.8 %id)
AI037902   .b 897 to 1346 450 to 1       450/450
(100 %)
8 diff
(98.3 %id)
AW772390 Kidney .b 897 to 1152 256 to 1       256/256
(100 %)
17 diff
(93.4 %id)
BX505773   .b 905 to 1445 1 to 541       541/541
(100 %)
2 diff
(99.7 %id)
DB560577 hypothalamus .b 910 to 1343 1 to 434     Submitted on the opposite strand 434/434
(100 %)
1 diff
(99.8 %id)
AA927845 pooled .b 910 to 1343 434 to 1       434/438
(99 %)
0 diff
(100 %id)
BE504061 pooled germ cell tumors .b 929 to 1343 415 to 1       415/415
(100 %)
4 diff
(99.1 %id)
BP383097 ilea mucosa .b 930 to 1347 1 to 420       420/429
(97 %)
4 diff
(99.1 %id)
AA127644 uterus .b 936 to 1343 406 to 1   fully sequenced,   406/406
(100 %)
0 diff
(100 %id)
CA772051 Pancreas, Purified pancreatic islet .b 936 to 1345 411 to 1   fully sequenced,   411/411
(100 %)
5 diff
(98.8 %id)
AA600243 bone marrow stroma .b 951 to 1342 392 to 1       392/392
(100 %)
0 diff
(100 %id)
AA905133 pooled .b 952 to 1343 392 to 1       392/393
(99 %)
1 diff
(99.8 %id)
AA148598   .b 957 to 1344 393 to 1       393/424
(92 %)
9 diff
(97.9 %id)
AI871555 carcinoid, lung .b 962 to 1349 388 to 1       388/392
(98 %)
11 diff
(97.2 %id)
AW028167 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 967 to 1347 380 to 1       380/381
(99 %)
2 diff
(99.5 %id)
AI580425 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 969 to 1344 378 to 1       378/393
(96 %)
4 diff
(99.0 %id)
F08651 brain, total brain .b 977 to 1330 1 to 354       354/354
(100 %)
2 diff
(99.5 %id)
AL049246 brain .b 987 to 4639 1 to 3650   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 3650/3650
(100 %)
16 diff
(99.6 %id)
CB047316 Kidney .b 993 to 1343 10 to 360   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 351/360
(97 %)
0 diff
(100 %id)
DA211586 brain .b 1015 to 1569 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DA122967 cerebellum .b 1016 to 1572 2 to 562   capped   561/561
(100 %)
4 diff
(99.3 %id)
BF197334 Kidney .b 1026 to 1344 319 to 1       319/319
(100 %)
1 diff
(99.7 %id)
BE927798 colon .b 1040 to 1203 182 to 16       167/198
(84 %)
0 diff
(100 %id)
BM463873 melanotic melanoma, skin .b 1062 to 2114 1 to 1051       1051/1060
(99 %)
29 diff
(97.3 %id)
W61341 heart .b 1071 to 1152 82 to 1       82/82
(100 %)
0 diff
(100 %id)
CB047315 Kidney .b 1092 to 1299 208 to 1   fully sequenced, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 208/208
(100 %)
1 diff
(99.6 %id)
N87182   .b 1131 to 1320 1 to 189       189/189
(100 %)
8 diff
(95.8 %id)
AL700255 human skeletal muscle .b 1136 to 1581 1 to 450       450/450
(100 %)
2 diff
(99.6 %id)
DA226507 brain .b 1145 to 1801 2 to 661   capped   660/660
(100 %)
2 diff
(99.7 %id)
BE172825 head_neck .b 1152 to 1292 141 to 1     Submitted on the opposite strand 141/141
(100 %)
0 diff
(100 %id)
CD653646 Embryonic Stem cells .b 1161 to 1984 11 to 832       822/839
(97 %)
17 diff
(98.0 %id)
BI495482 cochlea, ear .b 1165 to 1759 8 to 603       596/603
(98 %)
0 diff
(100 %id)
AA661699 alveolar rhabdomyosarcoma .b 1177 to 1361 1 to 186       186/190
(97 %)
9 diff
(95.3 %id)
AI885987 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 1180 to 1344 166 to 1       166/166
(100 %)
1 diff
(99.4 %id)
DB090728 testis .b 1202 to 1778 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DB213251 trachea .b 1262 to 1815 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
AI684650 pooled .b 1270 to 1588 322 to 2   tiling clone,   321/322
(99 %)
0 diff
(100 %id)
BX496164 Liver .b 1290 to 1728 1 to 440       440/440
(100 %)
4 diff
(99.1 %id)
AA199704   .b 1342 to 1857 526 to 9   tiling clone,   518/534
(97 %)
0 diff
(100 %id)
DA398166 thalamus .b 1344 to 1916 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
AA451615   .b 1363 to 1797 1 to 435       435/435
(100 %)
1 diff
(99.8 %id)
CD655951 Embryonic Stem cells .b 1374 to 2130 12 to 760       749/810
(92 %)
19 diff
(97.7 %id)
DB099318 testis .b 1382 to 1976 2 to 597   capped   596/596
(100 %)
2 diff
(99.7 %id)
DA042201 bladder .b 1444 to 1925 2 to 483   capped   482/482
(100 %)
1 diff
(99.8 %id)
DA042836 bladder .b 1449 to 2039 2 to 593   capped   592/592
(100 %)
4 diff
(99.4 %id)
DB215877 trachea .b 1462 to 2007 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
BM839671 Ascites, stomach .b 1471 to 1902 1 to 432       432/495
(87 %)
3 diff
(99.4 %id)
DA120906 cerebellum .b 1488 to 2018 2 to 533   capped   532/532
(100 %)
2 diff
(99.7 %id)
N29043 melanocyte .b 1496 to 1966 1 to 473       473/476
(99 %)
6 diff
(98.8 %id)
N36739 melanocyte .b 1497 to 1966 1 to 472       472/472
(100 %)
3 diff
(99.4 %id)
DA099373 cerebellum .b 1503 to 2045 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
BX476966   .b 1545 to 1685 1 to 147       147/156
(94 %)
9 diff
(94.3 %id)
DB173839 kidney, tumor tissue .b 1547 to 2139 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
AU151528   .b 1562 to 2018 458 to 1       458/469
(97 %)
2 diff
(99.6 %id)
DB164035 thymus .b 1615 to 2205 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
BI333433 cervical carcinoma cell line, cervix .b 1639 to 1857 1 to 217   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 217/217
(100 %)
4 diff
(98.2 %id)
BI261176 cervical carcinoma cell line, cervix .b 1645 to 2302 48 to 713       666/713
(93 %)
0 diff
(100 %id)
DB135245 thymus .b 1647 to 2190 2 to 545   capped   544/544
(100 %)
3 diff
(99.5 %id)
DA306283 hippocampus .b 1654 to 2210 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
AA329474   .b 1673 to 1871 1 to 199       199/320
(62 %)
1 diff
(99.7 %id)
CN410532 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1685 to 2290 1 to 606       606/606
(100 %)
2 diff
(99.7 %id)
CN410537 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1693 to 2236 1 to 544       544/544
(100 %)
1 diff
(99.9 %id)
DA536914 heart .b 1716 to 2290 2 to 574   capped   573/573
(100 %)
5 diff
(99.2 %id)
DB142940 thymus .b 1718 to 2279 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
AA417612 germinal center B cell .b 1722 to 2148 1 to 426       426/426
(100 %)
3 diff
(99.3 %id)
DA508464 brain .b 1741 to 2301 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
W70000 heart .b 1742 to 2188 1 to 448       448/448
(100 %)
7 diff
(98.5 %id)
DA289396 hippocampus .b 1760 to 2328 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA813789   .b 1779 to 2356 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA364045 subthalamic nucleus .b 1782 to 2343 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DA605615   .b 1784 to 2256 2 to 474   capped   473/473
(100 %)
1 diff
(99.8 %id)
DB144622 thymus .b 1784 to 2330 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA301398 hippocampus .b 1793 to 2377 2 to 587   capped   586/586
(100 %)
2 diff
(99.7 %id)
DB117578 thymus .b 1795 to 2353 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
BI756150 brain .b 1836 to 2519 1 to 674       674/675
(99 %)
18 diff
(97.4 %id)
TI_57220979   .b 1836 to 2519 64 to 737       674/738
(91 %)
18 diff
(97.6 %id)
DB159462 thymus .b 1843 to 2438 2 to 597   capped   596/596
(100 %)
6 diff
(99.0 %id)
DA439219 tongue, tumor tissue .b 1849 to 2387 2 to 540   tiling clone, capped   539/539
(100 %)
1 diff
(99.9 %id)
AI911722 pooled .b 1905 to 2409 1 to 505     Submitted on the opposite strand 505/505
(100 %)
2 diff
(99.7 %id)
AA831277 germinal center B cell .b 1928 to 2347 1 to 420     Submitted on the opposite strand 420/420
(100 %)
0 diff
(100 %id)
AI218343 pooled .b 1938 to 2388 1 to 451     Submitted on the opposite strand 451/451
(100 %)
0 diff
(100 %id)
AW182865 pooled .b 1938 to 2501 1 to 564     Submitted on the opposite strand 564/564
(100 %)
0 diff
(100 %id)
EH310611   .b 1943 to 2028 1 to 88       88/89
(98 %)
6 diff
(93.3 %id)
BQ771812 Chondrosarcoma Grade II, Left Pelvis .b 1954 to 2637 702 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 684/684
(100 %)
0 diff
(100 %id)
DA280879 corpus callosum .b 1973 to 2529 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB218006 trachea .b 1988 to 2550 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
DB254728 uterus .b 1988 to 2561 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA021761   .b 1993 to 2575 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
CN410536 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2005 to 2614 7 to 617       611/617
(99 %)
0 diff
(100 %id)
W79896 heart .b 2027 to 2306 1 to 285   fully sequenced,   285/285
(100 %)
1 diff
(99.7 %id)
BQ010450 Chondrosarcoma, Left Pubic Bone .b 2041 to 2637 615 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 597/597
(100 %)
1 diff
(99.9 %id)
EH340806   .b 2050 to 2142 1 to 93       93/93
(100 %)
0 diff
(100 %id)
AI927944 Kidney .b 2054 to 2644 590 to 1       590/590
(100 %)
9 diff
(98.5 %id)
BE617134 adenocarcinoma, colon .b 2055 to 2464 1 to 404       404/404
(100 %)
10 diff
(97.6 %id)
AI458582 carcinoid, lung .b 2075 to 2480 1 to 406     Submitted on the opposite strand 406/406
(100 %)
2 diff
(99.6 %id)
N26100 melanocyte .b 2082 to 2637 569 to 1       569/569
(100 %)
22 diff
(96.2 %id)
AV714269   .b 2084 to 2611 1 to 528       528/699
(75 %)
5 diff
(99.3 %id)
DB355649 whole embryo, mainly head .b 2087 to 2637 543 to 1       543/543
(100 %)
10 diff
(98.2 %id)
TI_154134681   .b 2101 to 2662 648 to 74       575/1107
(51 %)
0 diff
(100 %id)
DB364408   .b 2102 to 2637 536 to 1       536/566
(94 %)
8 diff
(98.6 %id)
AA332639 Embryo, 8 weeks .b 2107 to 2381 10 to 285       276/285
(96 %)
0 diff
(100 %id)
AW965435   .b 2107 to 2604 9 to 507       499/617
(80 %)
5 diff
(99.2 %id)
BI458578 brain, hypothalamus .b 2107 to 2171 691 to 757       734/777
(94 %)
28 diff
(96.4 %id)
DB266665 uterus .b 2126 to 2670 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
AA808190 germinal center B cell .b 2143 to 2646 503 to 1       503/503
(100 %)
4 diff
(99.3 %id)
AI148566 placenta .b 2149 to 2636 488 to 1       488/488
(100 %)
1 diff
(99.8 %id)
DA749942   .b 2149 to 2713 2 to 566   tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
DB044777 testis .b 2150 to 2685 2 to 536   capped   535/535
(100 %)
4 diff
(99.3 %id)
AI016593   .b 2157 to 2641 485 to 1       485/485
(100 %)
0 diff
(100 %id)
AI262141 Kidney .b 2159 to 2637 479 to 1       479/479
(100 %)
0 diff
(100 %id)
AA298989 uterus .b 2175 to 2427 1 to 253       253/253
(100 %)
0 diff
(100 %id)
N20666 melanocyte .b 2194 to 2637 448 to 1       448/448
(100 %)
3 diff
(99.4 %id)
DA876566 Prostate .b 2216 to 2745 2 to 532   capped   531/531
(100 %)
2 diff
(99.7 %id)
DA513241 brain .b 2217 to 2781 2 to 570   capped   569/569
(100 %)
6 diff
(99.0 %id)
DA735978   .b 2220 to 2975 2 to 759   capped   758/759
(99 %)
6 diff
(99.3 %id)
W70001 heart .b 2225 to 2638 424 to 1       424/435
(97 %)
12 diff
(97.3 %id)
DA651896   .b 2230 to 2819 2 to 592   capped   591/592
(99 %)
5 diff
(99.2 %id)
CD106865 brain, Pituitary .b 2232 to 3047 1 to 830       830/876
(94 %)
26 diff
(97.1 %id)
DA045813 bladder .b 2239 to 2763 2 to 527   capped   526/526
(100 %)
2 diff
(99.7 %id)
AA837014 lung, small cell carcinoma .b 2243 to 2637 395 to 1       395/395
(100 %)
0 diff
(100 %id)
DA453665 tongue, tumor tissue .b 2253 to 2845 2 to 598   capped   597/597
(100 %)
6 diff
(99.0 %id)
CD171845 testis .b 2261 to 3074 27 to 853       827/905
(91 %)
31 diff
(96.6 %id)
AA769565 germinal center B cell .b 2264 to 2576 360 to 48   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 313/313
(100 %)
0 diff
(100 %id)
W78011 heart .b 2276 to 2637 370 to 1   fully sequenced,   370/370
(100 %)
9 diff
(97.6 %id)
CN410538 embryonic stem cells, DMSO-treated H9 cellline .b 2280 to 2987 1 to 709       709/709
(100 %)
2 diff
(99.8 %id)
Z39634 brain, total brain .b 2293 to 2637 345 to 1       345/345
(100 %)
0 diff
(100 %id)
DB103471 thymus .b 2300 to 2870 2 to 573   capped   572/572
(100 %)
3 diff
(99.5 %id)
AA969699 Kidney, kidney tumor .b 2341 to 2632 293 to 1       293/293
(100 %)
1 diff
(99.7 %id)
AA847214 ovary .b 2345 to 2641 297 to 1       297/301
(98 %)
1 diff
(99.7 %id)
AI572503 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2396 to 2638 245 to 1       245/245
(100 %)
4 diff
(98.4 %id)
N44140 melanocyte .b 2408 to 2629 1 to 222       222/222
(100 %)
0 diff
(100 %id)
AA450212   .b 2460 to 2641 182 to 1       182/182
(100 %)
0 diff
(100 %id)
BG493240 lung, mucoepidermoid carcinoma .b 2502 to 2906 1 to 406       406/407
(99 %)
8 diff
(98.1 %id)
BF576647 muscle (skeletal) .b 2512 to 3077 1 to 556       556/839
(66 %)
33 diff
(96.1 %id)
AA434568   .b 2532 to 2638 1 to 107       107/107
(100 %)
2 diff
(98.2 %id)
DA307022 hippocampus .b 2533 to 3096 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
DA472166   .b 2534 to 3305 2 to 773   capped   772/774
(99 %)
9 diff
(98.9 %id)
DA693868   .b 2535 to 3112 2 to 579   capped   578/579
(99 %)
4 diff
(99.4 %id)
DA874695 Prostate .b 2558 to 3126 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
BX496505 Liver .b 2584 to 3033 1 to 455       455/455
(100 %)
7 diff
(98.5 %id)
DA510139 brain .b 2592 to 2921 2 to 331   capped   330/330
(100 %)
3 diff
(99.1 %id)
AW994671 breast_normal .b 2595 to 3226 1 to 630       630/630
(100 %)
14 diff
(97.8 %id)
BM724603 eye, fetal eye .b 2597 to 3255 119 to 773     Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 655/773
(84 %)
0 diff
(100 %id)
BQ718950 sympathetic trunk .b 2606 to 3483 1 to 877       877/878
(99 %)
9 diff
(99.0 %id)
BM905743 leiomyosarcoma, uterus .b 2634 to 3623 1 to 1000       1000/1062
(94 %)
37 diff
(96.6 %id)
BU507666 leiomyosarcoma, uterus .b 2640 to 3464 1 to 831       831/836
(99 %)
16 diff
(98.1 %id)
BG027560 Bone, osteosarcoma, cell line .b 2675 to 3363 12 to 699       688/772
(89 %)
0 diff
(100 %id)
BM821121 stomach .b 2685 to 3102 1 to 415       415/415
(100 %)
8 diff
(98.1 %id)
BG573138 placenta .b 2713 to 3436 1 to 727       727/758
(95 %)
21 diff
(97.3 %id)
BG036800 adenocarcinoma, cell line, Prostate .b 2723 to 3499 1 to 791       791/1006
(78 %)
48 diff
(95.3 %id)
BE564872 bladder, carcinoma, cell line .b 2760 to 3399 1 to 624       624/836
(74 %)
24 diff
(97.2 %id)
BQ717465 sympathetic trunk .b 2762 to 3624 1 to 871       871/902
(96 %)
20 diff
(97.8 %id)
BF668779 brain, primitive neuroectoderm .b 2767 to 3394 1 to 620       620/811
(76 %)
16 diff
(98.1 %id)
BF668094 brain, primitive neuroectoderm .b 2767 to 3420 1 to 646       646/863
(74 %)
23 diff
(97.4 %id)
BE883840 leiomyosarcoma, uterus .b 2772 to 3503 1 to 738       738/955
(77 %)
27 diff
(97.2 %id)
BF087658 head_neck .b 2773 to 3199 438 to 14       425/438
(97 %)
0 diff
(100 %id)
BF817680 colon_ins .b 2851 to 3368 1 to 516       516/516
(100 %)
8 diff
(98.5 %id)
BF892018 marrow .b 2852 to 3404 1 to 552       552/556
(99 %)
8 diff
(98.6 %id)
BF893289 marrow .b 2857 to 3224 1 to 367       367/367
(100 %)
10 diff
(97.3 %id)
C00243   .b 2872 to 3133 1 to 263       263/269
(97 %)
5 diff
(98.2 %id)
BF216753 brain, glioblastoma .b 2882 to 3524 1 to 623       623/801
(77 %)
24 diff
(97.1 %id)
AW651724 cervical carcinoma cell line, cervix .b 2893 to 3438 1 to 546       546/546
(100 %)
0 diff
(100 %id)
DB012837 esophageal, tumor tissue .b 2893 to 3452 2 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
BQ717555 sympathetic trunk .b 2964 to 3807 45 to 902       858/930
(92 %)
24 diff
(97.5 %id)
AI909061 breast .b 2986 to 3255 1 to 270       270/270
(100 %)
10 diff
(96.3 %id)
DN918489   .b 2999 to 3608 1 to 610   tiling clone,   610/610
(100 %)
2 diff
(99.7 %id)
BQ881524 sympathetic trunk .b 3021 to 3502 1 to 491       491/1351
(36 %)
23 diff
(98.3 %id)
BM904293 lymph, lymphoma, cell line .b 3060 to 3866 1 to 814   tiling clone,   814/1030
(79 %)
10 diff
(99.1 %id)
BF541741 hypernephroma, Kidney .b 3077 to 3737 1 to 661       661/670
(98 %)
21 diff
(96.9 %id)
DT217696 brain .b 3091 to 3715 1 to 625       625/625
(100 %)
2 diff
(99.7 %id)
AA357059   .b 3092 to 3328 1 to 237       237/237
(100 %)
1 diff
(99.6 %id)
CB216630 normal endometrium, mid-secretory phase,cycle day 23, uterus .b 3097 to 3699 1 to 603       603/603
(100 %)
1 diff
(99.9 %id)
BQ421230 embryonal carcinoma, cell line, testis .b 3163 to 4245 1 to 1078       1078/1080
(99 %)
6 diff
(99.5 %id)
BF816762 colon_ins .b 3169 to 3753 585 to 3     Submitted on the opposite strand 583/585
(99 %)
0 diff
(100 %id)
BG506733 lung .b 3189 to 3902 1 to 709       709/710
(99 %)
7 diff
(99.1 %id)
BE566464 bladder, carcinoma, cell line .b 3209 to 3800 1 to 588       588/880
(66 %)
28 diff
(96.9 %id)
DN912910   .b 3213 to 3884 1 to 664       664/670
(99 %)
17 diff
(97.5 %id)
BG610750 adenocarcinoma, Prostate .b 3222 to 3794 1 to 589       589/589
(100 %)
38 diff
(93.6 %id)
AA295784 Pancreas .b 3254 to 3353 1 to 100       100/101
(99 %)
1 diff
(99.1 %id)
AW959266   .b 3255 to 3798 1 to 542       542/544
(99 %)
23 diff
(95.8 %id)
AW959355   .b 3255 to 3659 1 to 406       406/407
(99 %)
16 diff
(96.1 %id)
BE895257 melanotic melanoma, skin .b 3261 to 3915 1 to 652       652/939
(69 %)
20 diff
(97.9 %id)
FN056724 breast carcinoma .b 3273 to 3379 1 to 107       107/107
(100 %)
0 diff
(100 %id)
BF815969 colon_ins .b 3274 to 3746 519 to 49     Submitted on the opposite strand 471/519
(90 %)
0 diff
(100 %id)
BI009724 kidney_tumor .b 3286 to 3841 10 to 562       553/563
(98 %)
16 diff
(97.2 %id)
BI008186 kidney_tumor .b 3288 to 3859 1 to 573       573/575
(99 %)
26 diff
(95.5 %id)
DN915693   .b 3290 to 3708 21 to 439       419/439
(95 %)
0 diff
(100 %id)
BF572036 melanotic melanoma, high MDR, skin .b 3333 to 4051 1 to 704       704/872
(80 %)
39 diff
(95.6 %id)
BI858688 breast, mammary adenocarcinoma, cell line .b 3345 to 4162 15 to 820       806/824
(97 %)
21 diff
(97.5 %id)
TI_57191437   .b 3345 to 4162 146 to 951       806/824
(97 %)
21 diff
(97.5 %id)
AW501282 lymph .b 3363 to 3764 18 to 419       402/419
(95 %)
0 diff
(100 %id)
TI_154156052   .b 3363 to 3855 90 to 582       493/503
(98 %)
0 diff
(100 %id)
R76944 placenta .b 3365 to 3667 1 to 304       304/337
(90 %)
9 diff
(97.4 %id)
AA625313 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 3365 to 3917 1 to 553       553/553
(100 %)
3 diff
(99.5 %id)
BF977026 melanotic melanoma, high MDR, skin .b 3378 to 4041 1 to 656       656/884
(74 %)
22 diff
(97.6 %id)
AI075024 colon, colon tumor .b 3381 to 3817 1 to 437     Submitted on the opposite strand 437/437
(100 %)
3 diff
(99.4 %id)
N83752   .b 3389 to 3602 1 to 210       210/210
(100 %)
14 diff
(93.4 %id)
BQ921720 leiomyosarcoma, uterus .b 3398 to 4306 1 to 908       908/909
(99 %)
8 diff
(99.2 %id)
BF695765 brain, primitive neuroectoderm .b 3413 to 4006 1 to 602       602/602
(100 %)
28 diff
(95.4 %id)
BI088920 cervix .b 3419 to 4015 1 to 607       607/770
(78 %)
35 diff
(95.5 %id)
BE176339 head_neck .b 3431 to 4072 1 to 638       638/666
(95 %)
15 diff
(97.8 %id)
FN106782 breast carcinoma .b 3449 to 3561 1 to 114       114/114
(100 %)
1 diff
(99.2 %id)
BM450024 melanotic melanoma, skin .b 3451 to 4327 1 to 884       884/1092
(80 %)
19 diff
(98.3 %id)
TI_57191187   .b 3483 to 4232 49 to 795       747/747
(100 %)
5 diff
(99.4 %id)
BI857992 breast, mammary adenocarcinoma, cell line .b 3484 to 4232 1 to 746       746/746
(100 %)
5 diff
(99.4 %id)
BF245117 brain, glioblastoma .b 3495 to 4180 1 to 675       675/911
(74 %)
43 diff
(95.3 %id)
DN914961   .b 3516 to 3953 1 to 438       438/438
(100 %)
2 diff
(99.6 %id)
AI909022 breast .b 3517 to 3901 397 to 13       385/397
(96 %)
0 diff
(100 %id)
CF596560 ovary .b 3520 to 4261 1 to 746       746/746
(100 %)
15 diff
(98.0 %id)
BI008085 kidney_tumor .b 3559 to 4124 568 to 8       561/568
(98 %)
0 diff
(100 %id)
CD104012 Pooled-Skin .b 3593 to 3729 1 to 137       137/139
(98 %)
3 diff
(97.9 %id)
BU741756 eye, fetal eye .b 3903 to 4642 752 to 19   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 734/744
(98 %)
6 diff
(99.2 %id)
AW675586 cervix .b 4105 to 4642 538 to 1       538/538
(100 %)
0 diff
(100 %id)
AW673185 cervical carcinoma cell line, cervix .b 4180 to 4645 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AA433890   .b 4223 to 4646 426 to 3   tiling clone,   424/426
(99 %)
0 diff
(100 %id)
DB368387   .b 4303 to 4642 340 to 1       340/347
(97 %)
0 diff
(100 %id)
N36135 melanocyte .b 4501 to 4642 143 to 1       143/143
(100 %)
1 diff
(99.4 %id)
NM_018155.2   .c -10 to 4647 1 to 4658 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 4658/4658
(100 %)
2 diff
(100.0 %id)
AK001480   .c 16 to 2015 1 to 2001 D216G tiling clone, available from FLJ,   2001/2001
(100 %)
3 diff
(99.9 %id)
BM311836 Pancreas, Purified pancreatic islet .c 747 to 1340 594 to 1       594/594
(100 %)
0 diff
(100 %id)
CK821680 Pancreas, Purified pancreatic islet .c 757 to 1350 594 to 1   tiling clone, Submitted on the opposite strand 594/594
(100 %)
0 diff
(100 %id)
BG899877 cartilage .d 1 to 331 86 to 416   tiling clone,   331/350
(94 %)
4 diff
(98.9 %id)
AI878970 brain, frontal lobe .d 214 to 681 32 to 499       468/499
(93 %)
0 diff
(100 %id)
AI879084 brain, frontal lobe .d 227 to 791 1 to 565   tiling clone,   565/565
(100 %)
0 diff
(100 %id)
AI928966 brain, frontal lobe .d 227 to 677 1 to 451       451/451
(100 %)
0 diff
(100 %id)
AI879529 brain, frontal lobe .d 882 to 1327 446 to 1   tiling clone,   446/446
(100 %)
2 diff
(99.6 %id)
AI929217 brain, frontal lobe .d 885 to 1327 443 to 1   tiling clone,   443/443
(100 %)
0 diff
(100 %id)
DN993789 brain, whole brain .e 1 to 664 1 to 664 A2E tiling clone,   664/664
(100 %)
4 diff
(99.4 %id)
BM925234 pooled lung and spleen .e 14 to 749 1 to 744       742/1098
(67 %)
30 diff
(97.3 %id)
CF121972 lymph .e 348 to 1075 8 to 734       727/734
(99 %)
0 diff
(100 %id)
TI_154181368   .e 348 to 1200 71 to 921   tiling clone,   851/855
(99 %)
12 diff
(98.6 %id)
DA216916 brain .e 516 to 982 2 to 468   capped   467/467
(100 %)
0 diff
(100 %id)
TI_59392041   .f 1 to 638 90 to 740 A89S I90Y L91S T92D C93M ... tiling clone,   651/689
(94 %)
33 diff
(95.3 %id)
BC036272.
matches multiple genes
breast, Breast, mammary adenocarcinoma., mammary adenocarcinoma, cell line .f 47 to 1202 1 to 1156   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base), also hits gene C1orf112 1156/1156
(100 %)
0 diff
(100 %id)
BC019859 Kidney, hypernephroma .f 47 to 1202 1 to 1156   available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1156/1156
(100 %)
1 diff
(100.0 %id)
DA242765 brain .f 620 to 1195 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BG707226 brain, hypothalamus .g 1 to 739 1 to 742 W2G tiling clone,   742/742
(100 %)
22 diff
(97.1 %id)
BG706527 brain, hypothalamus .g 1 to 722 1 to 720 W2G tiling clone,   720/722
(99 %)
19 diff
(97.4 %id)
DB499891 hypothalamus .g 10 to 512 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
DA103448 cerebellum .h 1 to 543 2 to 546 G29W I30Y S31I E32R T33D ... tiling clone, capped   545/545
(100 %)
2 diff
(99.7 %id)
BX108356 germinal center B cell .i 1 to 671 1 to 671   tiling clone,   671/671
(100 %)
1 diff
(99.9 %id)
DA225333 brain .i 434 to 982 2 to 550   tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
CN394751 embryonic stem cells, cell lines H1, H7, andH9 .i 693 to 1083 1 to 392       392/392
(100 %)
3 diff
(99.3 %id)
AW514168 pooled .i 742 to 1248 507 to 1       507/507
(100 %)
0 diff
(100 %id)
AI215625 pooled .i 765 to 1249 485 to 1       485/485
(100 %)
0 diff
(100 %id)
AA910033 pooled .i 782 to 1249 468 to 1       468/468
(100 %)
0 diff
(100 %id)
CN394749 embryonic stem cells, cell lines H1, H7, andH9 .i 784 to 1154 1 to 371       371/372
(99 %)
2 diff
(99.5 %id)
AA804487 germinal center B cell .i 836 to 1258 422 to 1       422/422
(100 %)
4 diff
(99.1 %id)
AA648267 germinal center B cell .i 845 to 1258 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AW592936 pooled .i 896 to 1249 354 to 1       354/354
(100 %)
0 diff
(100 %id)
AL692053   .i 899 to 1504 1 to 607       607/607
(100 %)
6 diff
(99.1 %id)
CN394750 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 926 to 1651 1 to 726   tiling clone,   726/726
(100 %)
0 diff
(100 %id)
CN394752 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 1134 to 1726 1 to 593   tiling clone,   593/593
(100 %)
1 diff
(99.9 %id)
AA478847 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 2083 to 2507 1 to 425   tiling clone,   425/425
(100 %)
0 diff
(100 %id)
DA832668 placenta .i 2402 to 3106 2 to 709   tiling clone, capped   708/710
(99 %)
5 diff
(99.3 %id)
AA255423 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 2454 to 2910 1 to 457   tiling clone,   457/457
(100 %)
1 diff
(99.8 %id)
AA255589 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 2464 to 2719 9 to 264       256/264
(96 %)
0 diff
(100 %id)
FN121182 breast carcinoma .i 2574 to 2641 66 to 1     Submitted on the opposite strand 66/66
(100 %)
4 diff
(94.0 %id)
CN410535 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 2841 to 3520 23 to 702   tiling clone,   680/702
(96 %)
0 diff
(100 %id)
CN410533 embryonic stem cells, cell lines H1, H7, andH9 .i 2970 to 3491 1 to 522       522/522
(100 %)
1 diff
(99.9 %id)
BG434621 placenta .i 3028 to 3752 10 to 718       709/721
(98 %)
30 diff
(95.9 %id)
AA291115 germinal center B cell .i 3071 to 3279 1 to 209       209/209
(100 %)
1 diff
(99.6 %id)
BM720906 eye, fetal eye .i 3117 to 3500 1 to 386   fully sequenced, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 386/386
(100 %)
2 diff
(99.5 %id)
BG027857 Bone, osteosarcoma, cell line .i 3150 to 3759 1 to 605       605/922
(65 %)
16 diff
(98.3 %id)
BI850465 Bone, osteosarcoma, cell line .i 3150 to 3749 1 to 593       593/593
(100 %)
8 diff
(98.7 %id)
AI525829 Prostate .i 3157 to 3680 15 to 543       529/1000
(52 %)
13 diff
(98.7 %id)
DB485705 hypothalamus .i 3158 to 3596 1 to 441       441/441
(100 %)
9 diff
(98.0 %id)
DA211215 brain .i 3203 to 3759 2 to 559   capped   558/559
(99 %)
5 diff
(99.2 %id)
H96761 melanocyte .i 3215 to 3633 1 to 428       428/428
(100 %)
21 diff
(95.1 %id)
BM724987 eye, fetal eye .i 3270 to 3843 1 to 574   fully sequenced,   574/574
(100 %)
0 diff
(100 %id)
BM676995 eye, fetal eye .i 3449 to 4136 706 to 19 G2X F4L tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 688/688
(100 %)
1 diff
(99.9 %id)
DB305181 brain .i 3612 to 4136 526 to 1       526/526
(100 %)
1 diff
(99.9 %id)
AA479944 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 3680 to 4137 457 to 1       457/457
(100 %)
1 diff
(99.8 %id)
AA255566 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 3741 to 4137 396 to 1       396/396
(100 %)
1 diff
(99.8 %id)
AA256550 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 3752 to 4135 385 to 1       385/390
(98 %)
3 diff
(99.3 %id)
AA291116 germinal center B cell .i 3754 to 4135 383 to 1       383/392
(97 %)
4 diff
(99.0 %id)
BM680206 eye, fetal eye .i 3813 to 4153 341 to 1   fully sequenced,   341/341
(100 %)
3 diff
(99.2 %id)
DB378967 placenta .i 3864 to 4379 516 to 1   tiling clone,   516/591
(87 %)
19 diff
(96.8 %id)
DA110296 cerebellum .j 1 to 561 2 to 562   tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
DA322651 hippocampus .j 7 to 560 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA456950 tongue, tumor tissue .j 7 to 580 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA216723 brain .j 12 to 559 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA455608 tongue, tumor tissue .j 14 to 572 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BY799150 eye .j 23 to 628 1 to 606 exact     606/606
(100 %)
0 diff
(100 %id)
DA128634 cerebellum .j 27 to 614 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
BP319356 pericardium .j 31 to 618 1 to 588       588/588
(100 %)
0 diff
(100 %id)
AL136803 testis .j 57 to 3592 1 to 3536 exact tiling clone, available from DKFZ, AAA   3536/3536
(100 %)
3 diff
(100.0 %id)
N29908 melanocyte .j 183 to 628 452 to 1 S2L Q3S R4P D5E T6G ...     452/471
(95 %)
10 diff
(97.9 %id)
AI863707 colon, colon tumor, RER+ .j 194 to 627 434 to 1 exact     434/434
(100 %)
0 diff
(100 %id)
AI803462   .j 202 to 630 429 to 1 exact     429/429
(100 %)
0 diff
(100 %id)
AI984336 Kidney .j 209 to 621 413 to 1       413/413
(100 %)
0 diff
(100 %id)
AI244784 Kidney .j 231 to 627 397 to 1       397/397
(100 %)
2 diff
(99.5 %id)
AI202881 pooled germ cell tumors .j 265 to 627 359 to 1       359/375
(95 %)
4 diff
(99.0 %id)
DB571036 hypothalamus .j 1110 to 1572 1 to 463     Submitted on the opposite strand 463/463
(100 %)
3 diff
(99.4 %id)
DB556224 hypothalamus .j 1119 to 1572 1 to 456     Submitted on the opposite strand 456/456
(100 %)
15 diff
(96.8 %id)
AA328481   .j 1628 to 1895 1 to 268       268/268
(100 %)
0 diff
(100 %id)
GD144688   .j 1657 to 1811 156 to 1     Submitted on the opposite strand 156/275
(56 %)
1 diff
(99.7 %id)
BG115311 duodenal adenocarcinoma, cell line, small intestine .j 2252 to 2988 1 to 717       717/841
(85 %)
26 diff
(97.0 %id)
CD642346 Embryonic Stem cells .j 2533 to 3138 57 to 660   tiling clone,   604/664
(90 %)
13 diff
(98.1 %id)
H92209 eye, retina .j 2730 to 2840 1 to 111     Submitted on the opposite strand 111/111
(100 %)
0 diff
(100 %id)
AA745825 2 pooled tumors (clear cell type), Kidney .j 2821 to 3141 323 to 2       322/323
(99 %)
0 diff
(100 %id)
DB539594 hippocampus .j 3121 to 3589 1 to 470     Submitted on the opposite strand 470/471
(99 %)
12 diff
(97.5 %id)
DB574319 hypothalamus .j 3131 to 3592 1 to 461     Submitted on the opposite strand 461/461
(100 %)
1 diff
(99.8 %id)
TI_151797793   .j 3139 to 3875 111 to 855   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 745/965
(77 %)
16 diff
(98.4 %id)
DB170340 kidney, tumor tissue .j 3246 to 3837 2 to 594   tiling clone, capped   593/593
(100 %)
1 diff
(99.9 %id)
AI934098 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 3386 to 3586 223 to 23   AAA   201/201
(100 %)
1 diff
(99.6 %id)
BJ997658 Wilms tumor .j 4160 to 4759 1 to 600   tiling clone,   600/600
(100 %)
0 diff
(100 %id)
TI_151714364   .j 4913 to 5556 733 to 90   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 644/644
(100 %)
1 diff
(99.9 %id)
DB347282 kidney, tumor tissue .j 5031 to 5556 526 to 1   tiling clone,   526/526
(100 %)
0 diff
(100 %id)
BJ997659 Wilms tumor .j 5201 to 5540 340 to 1       340/340
(100 %)
5 diff
(98.6 %id)
CN394748 embryonic stem cells, cell lines H1, H7, andH9 .j 5531 to 6231 1 to 701   tiling clone,   701/701
(100 %)
0 diff
(100 %id)
BX498527 Liver .j 5935 to 6418 1 to 484       484/484
(100 %)
4 diff
(99.2 %id)
AL697049 human skeletal muscle .j 5967 to 6586 1 to 620   tiling clone,   620/620
(100 %)
3 diff
(99.6 %id)
BG171562 hypernephroma, cell line, Kidney .k 1 to 737 1 to 734 exact tiling clone,   734/735
(99 %)
5 diff
(99.4 %id)
R70272 breast .k 402 to 792 1 to 394   tiling clone,   394/422
(93 %)
6 diff
(98.6 %id)
R70235 breast .k 788 to 1169 392 to 1   tiling clone,   392/483
(81 %)
25 diff
(94.9 %id)
BI598018 brain, hypothalamus .l 1 to 796 6 to 804 exact tiling clone,   799/806
(99 %)
5 diff
(99.4 %id)
TI_45213280   .l 1 to 796 124 to 922 exact     799/924
(86 %)
5 diff
(99.5 %id)
AW007855 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .l 750 to 1095 359 to 14   tiling clone, AAA   346/346
(100 %)
0 diff
(100 %id)
CN360654 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .l 857 to 1318 1 to 464   tiling clone,   464/464
(100 %)
8 diff
(98.3 %id)
DB264844 uterus .m-u 1 to 592 2 to 593   tiling clone, capped   592/592
(100 %)
2 diff
(99.7 %id)
BG029784 breast, mammary adenocarcinoma, cell line .m-u 11 to 751 15 to 764       750/1120
(66 %)
42 diff
(96.3 %id)
DN916153   .m-u 15 to 285 1 to 271       271/271
(100 %)
1 diff
(99.7 %id)
CB132897 Liver .m-u 26 to 607 1 to 582   tiling clone,   582/582
(100 %)
1 diff
(99.9 %id)
BI009728 kidney_tumor .m-u 27 to 545 525 to 9       517/525
(98 %)
0 diff
(100 %id)
BE219994 carcinoid, lung .m-u 43 to 260 1 to 218     Submitted on the opposite strand 218/218
(100 %)
1 diff
(99.6 %id)
FN157255 breast carcinoma .m-u 45 to 160 1 to 115       115/115
(100 %)
3 diff
(97.4 %id)
EH310274   .m-u 54 to 111 1 to 57       57/57
(100 %)
1 diff
(98.3 %id)
AA251651 germinal center B cell .m-u 54 to 486 1 to 433       433/433
(100 %)
0 diff
(100 %id)
BF110469 carcinoid, lung .m-u 58 to 546 8 to 496     Submitted on the opposite strand 489/496
(98 %)
0 diff
(100 %id)
BG149263 carcinoid, lung .m-u 75 to 336 1 to 262     Submitted on the opposite strand 262/262
(100 %)
1 diff
(99.7 %id)
BE535538 cervix .m-u 75 to 854 1 to 780       780/780
(100 %)
28 diff
(96.5 %id)
AI701394 carcinoid, lung .m-u 77 to 608 1 to 533     Submitted on the opposite strand 533/533
(100 %)
2 diff
(99.7 %id)
TI_149307631   .m-u 99 to 1031 1025 to 96 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 930/1020
(91 %)
35 diff
(96.6 %id)
BF977143 melanotic melanoma, high MDR, skin .m-u 100 to 740 1 to 636       636/741
(85 %)
17 diff
(97.8 %id)
TI_154107802   .m-u 105 to 1031 992 to 86 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 907/967
(93 %)
35 diff
(96.4 %id)
BI009711 kidney_tumor .m-u 106 to 507 409 to 1       409/451
(90 %)
28 diff
(93.8 %id)
BF999160 placenta_normal .m-u 120 to 500 11 to 393       383/393
(97 %)
0 diff
(100 %id)
TI_154107600   .m-u 153 to 1031 975 to 100 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 876/992
(88 %)
13 diff
(98.7 %id)
BM714142 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .m-u 208 to 858 1 to 651   fully sequenced,   651/651
(100 %)
0 diff
(100 %id)
BM821167 stomach .m-u 254 to 627 1 to 374       374/374
(100 %)
0 diff
(100 %id)
AI310331 2 pooled tumors (clear cell type), Kidney .m-u 259 to 683 436 to 12   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 425/425
(100 %)
0 diff
(100 %id)
FN114205 breast carcinoma .m-u 261 to 326 1 to 66       66/67
(98 %)
1 diff
(98.6 %id)
BG573841 placenta .m-u 270 to 1004 1 to 738 W21R V26F Y27M V28*     738/738
(100 %)
14 diff
(98.2 %id)
BQ014771 Chondrosarcoma, Left Pubic Bone .m-u 282 to 1031 767 to 19 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 749/749
(100 %)
1 diff
(99.9 %id)
AA659124 alveolar rhabdomyosarcoma .m-u 290 to 555 8 to 273       266/276
(96 %)
3 diff
(99.0 %id)
FN167211 breast carcinoma .m-u 292 to 392 1 to 101       101/103
(98 %)
1 diff
(99.1 %id)
DN915694   .m-u 297 to 959 658 to 1 L33P     658/658
(100 %)
7 diff
(99.0 %id)
FN126516 breast carcinoma .m-u 299 to 402 1 to 104       104/108
(96 %)
1 diff
(99.1 %id)
DN914960   .m-u 306 to 959 654 to 1 exact     654/654
(100 %)
0 diff
(100 %id)
BG547567 lung .m-u 306 to 954 1 to 645 F15L V16C F17L I18*     645/645
(100 %)
5 diff
(99.3 %id)
DN912909   .m-u 309 to 959 651 to 1 exact     651/651
(100 %)
3 diff
(99.6 %id)
AW020468 cochlea, ear .m-u 311 to 680 7 to 376   fully sequenced,   370/376
(98 %)
0 diff
(100 %id)
AA278712 germinal center B cell .m-u 316 to 760 1 to 445       445/445
(100 %)
1 diff
(99.8 %id)
FN124067 breast carcinoma .m-u 336 to 392 56 to 1     Submitted on the opposite strand 56/57
(98 %)
1 diff
(98.3 %id)
BE537837 cervix .m-u 336 to 1019 1 to 681 F11L D12T S13Q V14F F15C ...     681/687
(99 %)
15 diff
(97.9 %id)
BU621742 cell lines, Chondrosarcoma .m-u 348 to 1036 706 to 19 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 688/688
(100 %)
3 diff
(99.6 %id)
BF246444 brain, glioblastoma .m-u 351 to 1035 1 to 678 F11L F15L V16C I18Y N19K ...     678/829
(81 %)
30 diff
(96.4 %id)
CA447231 Chondrosarcoma, Left Pelvis .m-u 351 to 1031 696 to 16 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 681/681
(100 %)
6 diff
(99.2 %id)
BI059043 placenta_normal .m-u 352 to 915 563 to 1 exact     563/564
(99 %)
10 diff
(98.3 %id)
BM979381 lung, Primary Lung Epithelial Cells .m-u 363 to 1031 687 to 19 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 669/669
(100 %)
3 diff
(99.6 %id)
BM998210 lung, Metastatic Chondrosarcoma .m-u 378 to 1037 676 to 18 exact     659/684
(96 %)
0 diff
(100 %id)
BM689459 eye, Retina Foveal and Macular .m-u 378 to 675 7 to 304   fully sequenced, Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 298/304
(98 %)
0 diff
(100 %id)
CA447072 Chondrosarcoma, Left Pelvis .m-u 386 to 1031 664 to 19 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 646/646
(100 %)
0 diff
(100 %id)
CA312029 Human Lung Epithelial cells, lung .m-u 390 to 1028 6 to 644 exact   Submitted on the opposite strand 639/650
(98 %)
6 diff
(99.1 %id)
H46637 breast .m-u 401 to 903 1 to 517 N22X     517/517
(100 %)
20 diff
(96.2 %id)
AI632755 Kidney .m-u 402 to 1031 630 to 1 exact     630/630
(100 %)
1 diff
(99.9 %id)
H44674 breast .m-u 413 to 812 1 to 414       414/414
(100 %)
21 diff
(95.0 %id)
BF439189 pooled .m-u 426 to 1031 607 to 1 V14G     607/607
(100 %)
3 diff
(99.6 %id)
FN057900 breast carcinoma .m-u 459 to 555 98 to 6     Submitted on the opposite strand 93/102
(91 %)
0 diff
(100 %id)
AI627794 Kidney .m-u 466 to 1031 566 to 1 exact     566/566
(100 %)
0 diff
(100 %id)
CB105486 Liver .m-u 473 to 1033 1 to 561 exact     561/561
(100 %)
3 diff
(99.5 %id)
CB106074 Liver .m-u 473 to 1015 1 to 543 exact     543/543
(100 %)
2 diff
(99.7 %id)
CB106022 Liver .m-u 474 to 1000 1 to 526 exact     526/526
(100 %)
1 diff
(99.9 %id)
BF446464 carcinoid, lung .m-u 482 to 1035 557 to 3 L4P V5C E6R T7N F9I ...     555/557
(99 %)
0 diff
(100 %id)
AW779883 Kidney .m-u 490 to 1033 544 to 1 exact     544/544
(100 %)
0 diff
(100 %id)
FN107152 breast carcinoma .m-u 493 to 600 105 to 1     Submitted on the opposite strand 105/105
(100 %)
6 diff
(94.3 %id)
AI417161 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m-u 504 to 1035 533 to 2 exact     532/533
(99 %)
0 diff
(100 %id)
BM552452 leiomyosarcoma, uterus .m-u 504 to 1039 29 to 563 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 535/563
(95 %)
0 diff
(100 %id)
BG236476 blood, lymphocyte .m-u 507 to 1033 527 to 1 exact     527/527
(100 %)
0 diff
(100 %id)
AI521744 Kidney .m-u 509 to 1031 522 to 1 exact     522/522
(100 %)
2 diff
(99.7 %id)
BF594417 colon, colon tumor, RER+ .m-u 509 to 1031 523 to 1 exact     523/523
(100 %)
0 diff
(100 %id)
DN914044   .m-u 512 to 959 448 to 1 exact     448/448
(100 %)
2 diff
(99.6 %id)
AA448566   .m-u 513 to 663 1 to 151   fully sequenced,   151/151
(100 %)
0 diff
(100 %id)
AA884469   .m-u 514 to 1035 522 to 1 exact     522/522
(100 %)
0 diff
(100 %id)
BF064234 pooled .m-u 522 to 1030 509 to 1 exact     509/509
(100 %)
0 diff
(100 %id)
DB569979 hypothalamus .m-u 529 to 1030 1 to 503 exact   Submitted on the opposite strand 503/503
(100 %)
9 diff
(98.3 %id)
AW514918 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .m-u 529 to 1035 507 to 1 exact     507/507
(100 %)
0 diff
(100 %id)
AW276033 lung, two pooled squamous cell carcinomas .m-u 530 to 1031 502 to 1 exact     502/502
(100 %)
0 diff
(100 %id)
FN134077 breast carcinoma .m-u 540 to 653 116 to 1     Submitted on the opposite strand 116/116
(100 %)
1 diff
(99.2 %id)
DN916152   .m-u 546 to 959 414 to 1 exact     414/415
(99 %)
1 diff
(99.8 %id)
BU754288 placenta .m-u 553 to 1036 498 to 14 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 485/485
(100 %)
1 diff
(99.8 %id)
AI978767 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .m-u 556 to 1032 477 to 1 exact     477/477
(100 %)
0 diff
(100 %id)
DB546873 hippocampus .m-u 559 to 1035 1 to 477 exact   Submitted on the opposite strand 477/478
(99 %)
1 diff
(99.8 %id)
BE350283 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .m-u 559 to 1035 477 to 1 exact     477/477
(100 %)
1 diff
(99.8 %id)
AI991555 Kidney .m-u 561 to 1034 474 to 1 exact     474/474
(100 %)
0 diff
(100 %id)
AW194437 serous papillary carcinoma, high grade, 2pooled tumors, uterus .m-u 561 to 1036 476 to 1 exact     476/476
(100 %)
0 diff
(100 %id)
AW301187 Kidney .m-u 561 to 1037 478 to 2 exact     477/478
(99 %)
0 diff
(100 %id)
AW511119 pooled .m-u 561 to 1033 473 to 1 exact     473/473
(100 %)
1 diff
(99.8 %id)
AI051324 parathyroid gland, parathyroid tumor .m-u 562 to 1035 477 to 4 exact     474/477
(99 %)
0 diff
(100 %id)
AW271236 Kidney .m-u 567 to 1031 512 to 48 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 465/465
(100 %)
0 diff
(100 %id)
AI168827 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m-u 569 to 1033 464 to 1 V26F Y27M V28*     464/464
(100 %)
1 diff
(99.8 %id)
DB552097 hippocampus .m-u 571 to 1031 1 to 461 exact   Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
DN918490   .m-u 572 to 959 388 to 1 exact     388/388
(100 %)
5 diff
(98.8 %id)
AI168428 pooled .m-u 574 to 1030 457 to 1 exact     457/457
(100 %)
0 diff
(100 %id)
AW967659   .m-u 577 to 1031 457 to 3 L2P D32A   Submitted on the opposite strand 455/457
(99 %)
0 diff
(100 %id)
AA743631 germinal center B cell .m-u 577 to 893 317 to 1 F15L F17Y     317/317
(100 %)
2 diff
(99.4 %id)
DB545179 hippocampus .m-u 578 to 1029 1 to 452 exact   Submitted on the opposite strand 452/454
(99 %)
1 diff
(99.8 %id)
BE179474 head_neck .m-u 579 to 797 225 to 7     Submitted on the opposite strand 219/230
(95 %)
0 diff
(100 %id)
DB554737 hypothalamus .m-u 582 to 1031 1 to 450 exact   Submitted on the opposite strand 450/450
(100 %)
0 diff
(100 %id)
AI569095 adenocarcinoma, Pancreas .m-u 582 to 1034 453 to 1 exact     453/453
(100 %)
0 diff
(100 %id)
BE172268 head_neck .m-u 583 to 837 255 to 1     Submitted on the opposite strand 255/255
(100 %)
0 diff
(100 %id)
AI281481 lymph node, mantle cell lymphoma .m-u 584 to 1031 448 to 1 exact     448/448
(100 %)
0 diff
(100 %id)
AI859112 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .m-u 588 to 1036 449 to 1 exact     449/449
(100 %)
0 diff
(100 %id)
AW292479   .m-u 590 to 1037 464 to 17 exact     448/464
(96 %)
0 diff
(100 %id)
BE041813 pooled .m-u 594 to 1024 431 to 1 exact   Submitted on the opposite strand 431/431
(100 %)
0 diff
(100 %id)
BF941060 dorsal root ganglia .m-u 595 to 1032 438 to 1 exact     438/438
(100 %)
1 diff
(99.8 %id)
BF055086 pooled .m-u 595 to 1035 444 to 4 exact     441/444
(99 %)
0 diff
(100 %id)
FN071638 breast carcinoma .m-u 600 to 657 1 to 59       59/60
(98 %)
2 diff
(96.7 %id)
AW075626 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .m-u 602 to 1036 453 to 19 D32A AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 435/435
(100 %)
4 diff
(99.1 %id)
FN052157 breast carcinoma .m-u 605 to 716 1 to 112       112/112
(100 %)
0 diff
(100 %id)
CB070141 Pancreas, Purified pancreatic islet .m-u 615 to 1031 1 to 417 V35F AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 417/417
(100 %)
8 diff
(98.1 %id)
H98013 melanocyte .m-u 617 to 1036 429 to 2 L2F L3M V5L E6X T7C ...     428/431
(99 %)
0 diff
(100 %id)
AI953954 brain, three pooled meningiomas .m-u 617 to 1036 432 to 13 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 420/420
(100 %)
0 diff
(100 %id)
AI624812 pooled germ cell tumors .m-u 618 to 1033 416 to 1 exact     416/416
(100 %)
2 diff
(99.6 %id)
AW591031 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .m-u 618 to 1031 414 to 1 exact     414/414
(100 %)
4 diff
(99.1 %id)
AA449711   .m-u 633 to 1036 404 to 1 exact fully sequenced,   404/404
(100 %)
1 diff
(99.8 %id)
AA173614   .m-u 644 to 1016 375 to 1 exact   Submitted on the opposite strand 375/383
(97 %)
4 diff
(99.0 %id)
DB535318 hippocampus .m-u 645 to 1035 1 to 391 V14I F15L A37G   Submitted on the opposite strand 391/392
(99 %)
16 diff
(96.0 %id)
BU726619 eye, Retina Foveal and Macular .m-u 645 to 1031 405 to 19 exact fully sequenced, AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 387/387
(100 %)
0 diff
(100 %id)
BI491488 cochlea, ear .m-u 650 to 1028 379 to 1 exact fully sequenced,   379/379
(100 %)
0 diff
(100 %id)
AA825772 germinal center B cell .m-u 656 to 1031 386 to 11 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 376/376
(100 %)
0 diff
(100 %id)
DB533171 hippocampus .m-u 674 to 1031 1 to 356 F9L F11L D12S V14G A37G   Submitted on the opposite strand 356/356
(100 %)
13 diff
(96.4 %id)
BF026244 melanotic melanoma, skin .m-u 674 to 1030 1 to 354 F11L D12T S13Q V14F F15C ...     354/354
(100 %)
3 diff
(99.2 %id)
AW518673 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .m-u 675 to 1035 361 to 1 exact     361/361
(100 %)
0 diff
(100 %id)
BF447593 sympathetic trunk .m-u 678 to 1031 353 to 1 exact     353/353
(100 %)
1 diff
(99.8 %id)
AI198635   .m-u 688 to 1031 359 to 16 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 344/344
(100 %)
0 diff
(100 %id)
AI678624 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .m-u 688 to 1031 344 to 1 exact     344/344
(100 %)
0 diff
(100 %id)
BU508488 leiomyosarcoma, uterus .m-u 688 to 1031 24 to 367 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 344/367
(93 %)
0 diff
(100 %id)
CB048330 Prostate .m-u 693 to 1031 9 to 347 exact AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 339/347
(97 %)
0 diff
(100 %id)
AA865892 Kidney .m-u 703 to 1036 334 to 1 exact     334/334
(100 %)
2 diff
(99.5 %id)
BF431559 Kidney .m-u 708 to 1031 325 to 1 exact     325/325
(100 %)
1 diff
(99.7 %id)
BF447468 sympathetic trunk .m-u 708 to 1032 324 to 1 exact     324/324
(100 %)
2 diff
(99.4 %id)
FN047122 breast carcinoma .m-u 710 to 820 113 to 1     Submitted on the opposite strand 113/117
(96 %)
9 diff
(92.4 %id)
FN078706 breast carcinoma .m-u 710 to 820 110 to 1     Submitted on the opposite strand 110/114
(96 %)
10 diff
(91.3 %id)
AA251550 germinal center B cell .m-u 713 to 1032 320 to 1 exact     320/320
(100 %)
2 diff
(99.4 %id)
AI689529 serous papillary carcinoma, high grade, 2pooled tumors, uterus .m-u 713 to 1031 320 to 1 exact     320/320
(100 %)
7 diff
(97.9 %id)
AW593588 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .m-u 714 to 1031 317 to 1 exact     317/317
(100 %)
1 diff
(99.7 %id)
AA452248   .m-u 715 to 1035 323 to 3 exact     321/323
(99 %)
0 diff
(100 %id)
AI216855   .m-u 715 to 1033 318 to 1 exact     318/318
(100 %)
1 diff
(99.7 %id)
FN164116 breast carcinoma .m-u 724 to 822 98 to 1     Submitted on the opposite strand 98/99
(98 %)
1 diff
(99.0 %id)
AW243391 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .m-u 724 to 1033 317 to 1 exact     317/317
(100 %)
7 diff
(97.8 %id)
FN138906 breast carcinoma .m-u 736 to 856 120 to 1     Submitted on the opposite strand 120/120
(100 %)
3 diff
(97.5 %id)
AI205697   .m-u 742 to 1034 293 to 1 exact     293/293
(100 %)
0 diff
(100 %id)
N66362 cochlea, ear .m-u 750 to 1052 308 to 6 exact tiling clone,   303/310
(97 %)
0 diff
(100 %id)
AI918718 pooled germ cell tumors .m-u 768 to 1033 266 to 1       266/266
(100 %)
0 diff
(100 %id)
FN114948 breast carcinoma .m-u 775 to 871 1 to 97       97/98
(98 %)
1 diff
(99.0 %id)
AA854270 parathyroid gland, parathyroid tumor .m-u 796 to 1031 257 to 22   AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) 236/236
(100 %)
0 diff
(100 %id)
AI570307 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .m-u 810 to 1034 225 to 1       225/225
(100 %)
0 diff
(100 %id)
FN150195 breast carcinoma .m-u 823 to 907 1 to 85       85/86
(98 %)
1 diff
(98.9 %id)
BU738854 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .m-u 828 to 1041 223 to 9   fully sequenced,   215/223
(96 %)
8 diff
(96.5 %id)
FN159840 breast carcinoma .m-u 832 to 936 1 to 106       106/106
(100 %)
1 diff
(99.1 %id)
AW151445 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .m-u 853 to 1032 180 to 1       180/180
(100 %)
0 diff
(100 %id)
DW461746 Liver .m-u 859 to 966 17 to 124       108/124
(87 %)
0 diff
(100 %id)
DW460532 Liver .m-u 912 to 1032 17 to 137       121/137
(88 %)
0 diff
(100 %id)
AW975492   .n 1 to 633 640 to 5     Submitted on the opposite strand 634/660
(96 %)
8 diff
(98.8 %id)
BX096581 germinal center B cell .n 4 to 633 1 to 630   tiling clone,   630/634
(99 %)
1 diff
(99.9 %id)
AW978316   .n 5 to 633 636 to 7     Submitted on the opposite strand 630/680
(92 %)
16 diff
(97.7 %id)
AA284368 germinal center B cell .n 10 to 427 1 to 418   fully sequenced,   418/418
(100 %)
0 diff
(100 %id)
GD153518   .n 196 to 442 249 to 1     Submitted on the opposite strand 249/349
(71 %)
4 diff
(98.9 %id)
AA828359 germinal center B cell .n 254 to 633 421 to 42       380/421
(90 %)
0 diff
(100 %id)
AA687349 germinal center B cell .n 267 to 633 406 to 40       367/406
(90 %)
0 diff
(100 %id)
DA190685 amygdala .n 347 to 943 2 to 599 exact tiling clone, capped   598/598
(100 %)
2 diff
(99.7 %id)
AA284369 germinal center B cell .n 397 to 633 244 to 8   fully sequenced,   237/244
(97 %)
1 diff
(99.6 %id)
AW293921   .o-u 1 to 447 464 to 18 exact tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 447/447
(100 %)
0 diff
(100 %id)
BF446082 breast, invasive ductal carcinoma, 3 pooled samples .o-u 7 to 450 444 to 1 exact tiling clone,   444/444
(100 %)
0 diff
(100 %id)
AA503279 Prostate .o-u 157 to 447 9 to 299   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 291/299
(97 %)
0 diff
(100 %id)
AV753285 Pituitary Gene SLC25A36, variant not shown         This clone was ignored    
AV727257 hypothalamus Gene SLC25A36, variant not shown         Suspected internal deletion, this clone was ignored    
BX496705 Liver Gene SLC25A36, variant not shown              
AV746715 Pituitary Gene SLC25A36, variant not shown              
AL036519 brain Gene SLC25A36, variant not shown         This clone was ignored    
AL036520 brain Gene SLC25A36, variant not shown       AAA This clone was ignored    
BI008123 kidney_tumor Gene SLC25A36, variant not shown              
DB303325 amygdala Gene SLC25A36, variant not shown              
DA189547 amygdala Gene SLC25A36, variant not shown       capped      
CR748416 pooled Gene SLC25A36, variant not shown              
BX107558 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors Gene SLC25A36, variant not shown       AAA Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base)    
DR979020 placenta Gene SLC25A36, variant not shown         Submitted on the opposite strand    
AA076294   Gene SLC25A36, variant not shown         This clone was ignored    
AA102789 lung, lung carcinoma Gene SLC25A36, variant not shown         Submitted on the opposite strand    
AA206767   Gene SLC25A36, variant not shown              
AA206801   Gene SLC25A36, variant not shown              
AI287445 Kidney, renal cell tumor Gene SLC25A36, variant not shown              
AI564709 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus Gene SLC25A36, variant not shown              
AI924709 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors Gene SLC25A36, variant not shown              
AI942281 Kidney Gene SLC25A36, variant not shown         This clone was ignored    
BF218109 brain, glioblastoma Gene SLC25A36, variant not shown         Suspected internal deletion, this clone was ignored    
BF668176 brain, primitive neuroectoderm Gene SLC25A36, variant not shown              
CX165337 human embryonic stem cells differentiated toan early endodermal cell type Gene SLC25A36, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n, .o-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI